Back

Remepy Announces Collaboration with Merck KGaA, Darmstadt Germany to Advance Hybrid Drugs Across Therapeutic Areas

April 28, 2026

More like this

May 3, 2026

Merck KGaA taps into Remepy’s Hybrid Drug platform

The Pharma Letter

April 29, 2026

Remepy, Merck KGaA pair up to test app-paired drug model in rare tumour

FirstWord Pharma

April 28, 2026

Remepy to Collaborate with Merck KGaA, Darmstadt Germany to Advance Hybrid Drugs Across Therapeutic Areas

American Pharmaceutical Review